VolitionRx (NYSE:VNRX) Now Covered by HC Wainwright
HC Wainwright assumed coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $2.50 price target on the stock. HC Wainwright’s target price suggests a potential upside of 406.07% from the stock’s previous close. HC Wainwright also issued estimates […]
